QCMC
ABBV icon

Quantum Capital Management (California)’s AbbVie ABBV Stock Holding History

Quantum Capital Management (California)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,629
Closed -$1.04M – 223
2020
Q2 		$1.04M Sell
10,629
-1,580
-13% -$139K 0.61% 37
2020
Q1 		$930K Sell
12,209
-550
-4% -$46.8K 0.62% 45
2019
Q4 		$1.13M Buy
12,759
+250
+2% +$20.8K 0.54% 57
2019
Q3 		$947K Buy
12,509
+746
+6% +$51.1K 0.48% 66
2019
Q2 		$855K Sell
11,763
-554
-4% -$43.5K 0.47% 74
2019
Q1 		$993K Sell
12,317
-140
-1% -$11.5K 0.53% 54
2018
Q4 		$1.15M Buy
12,457
+3,404
+38% +$299K 0.67% 49
2018
Q3 		$856K Sell
9,053
-38
-0.4% -$3.6K 0.31% 103
2018
Q2 		$842K Sell
9,091
-191
-2% -$18.7K 0.32% 106
2018
Q1 		$879K Sell
9,282
-814
-8% -$89.4K 0.21% 96
2017
Q4 		$976K Sell
10,096
-791
-7% -$74.5K 0.23% 89
2017
Q3 		$967K Sell
10,887
-85
-0.8% -$6.47K 0.23% 92
2017
Q2 		$796K Sell
10,972
-45
-0.4% -$3.02K 0.2% 83
2017
Q1 		$718K Sell
11,017
-5,257
-32% -$331K 0.18% 87
2016
Q4 		$1.02M Sell
16,274
-228
-1% -$13.9K 0.27% 73
2016
Q3 		$1.04M Sell
16,502
-741
-4% -$48K 0.29% 71
2016
Q2 		$1.07M Sell
17,243
-191
-1% -$11.6K 0.15% 72
2016
Q1 		$996K Sell
17,434
-572
-3% -$31.9K 0.14% 78
2015
Q4 		$1.07M Sell
18,006
-1,846
-9% -$106K 0.14% 73
2015
Q3 		$1.08M Buy
19,852
+190
+1% +$12.4K 0.17% 70
2015
Q2 		$1.32M Sell
19,662
-21,642
-52% -$1.41M 0.19% 68
2015
Q1 		$2.4M Buy
41,304
+12,151
+42% +$734K 0.53% 64
2014
Q4 		$1.91M Sell
29,153
-29,888
-51% -$1.88M 0.43% 61
2014
Q3 		$3.41M Sell
59,041
-11,699
-17% -$650K 0.67% 60
2014
Q2 		$3.99M Buy
+70,740
New +$3.71M 0.68% 64
2014
Q1 		– Sell
-62,636
Closed -$3.31M – 176
2013
Q4 		$3.31M Buy
62,636
+4,586
+8% +$225K 0.56% 72
2013
Q3 		$2.6M Buy
+58,050
New +$2.57M 0.51% 75

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Quantum Capital Management (California)'s ABBV Position: Q3 2020 in Review

Quantum Capital Management (California) sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 10,629 shares — an estimated $1.04M sold.

Quantum Capital Management (California) first reported a position in ABBV in Q3 2013 and held it in 27 quarters. The position peaked at $3.99M in Q2 2014. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Quantum Capital Management (California) reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • Quantum Capital Management (California) sold 10,629 AbbVie shares in Q3 2020, an estimated $1.04M.
  • Quantum Capital Management (California) first reported a position in AbbVie in Q3 2013 and held it in 27 quarters.
  • Quantum Capital Management (California)'s AbbVie position peaked at $3.99M in Q2 2014.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.